Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lantheus (LNTH)
NASDAQ:LNTH
Holding LNTH?
Track your performance easily
LNTH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$50.20 - $126.89
Previous Close$105.54
Volume611.65K
Average Volume (3M)1.09M
Market Cap
$7.33B
Enterprise Value$7.13B
Total Cash (Recent Filing)$757.02M
Total Debt (Recent Filing)$564.06M
Price to Earnings (P/E)17.3
Beta0.76
Next Earnings
Oct 31, 2024EPS Estimate
$1.56Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.11
Shares Outstanding69,430,642
10 Day Avg. Volume623,369
30 Day Avg. Volume1,092,904
Standard Deviation0.17
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)7.14
Price to Sales (P/S)5.19
Price to Cash Flow (P/CF)21.60
P/FCF Ratio46.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.96
Enterprise Value/Gross Profit10.06
Enterprise Value/Ebitda16.64
Forecast
1Y Price Target
$146.25Price Target Upside35.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Lantheus News
Bulls Say, Bears Say
Bulls Say
Earnings2Q24 total revenue of $394.1M came above prior guidance of $380M - $390M and beat estimate of $379.6M.
Product PerformancePYLARIFY remains the key revenue driver, while DEFINITY continues strong growth and opportunistic TechneLite sales contributed to quarter overperformance.
Strategic InitiativesKey focus on expanding therapeutic and diagnostic radiopharmaceutical pipeline acquired via recent BD activity.
Bears Say
Commercial CompetitivenessThe recent weakness in Lantheus stock has been driven by concern over the potential commercial competitiveness of PNT2002 following the topline SPLASH results.
EarningsAdjusted EPS for the quarter was $1.80, slightly below the consensus of $1.83.
R&D InvestmentsDecrease driven by R&D investments and anticipated increases in share count related to the convertible debt instrument.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LNTH FAQ
What was Lantheus’s price range in the past 12 months?
Lantheus lowest stock price was $50.20 and its highest was $126.89 in the past 12 months.
What is Lantheus’s market cap?
Currently, no data Available
When is Lantheus’s upcoming earnings report date?
Lantheus’s upcoming earnings report date is Oct 31, 2024 which is in 42 days.
How were Lantheus’s earnings last quarter?
Lantheus released its earnings results on Jul 31, 2024. The company reported $1.8 earnings per share for the quarter, missing the consensus estimate of $1.83 by -$0.03.
Is Lantheus overvalued?
According to Wall Street analysts Lantheus’s price is currently Undervalued.
Does Lantheus pay dividends?
Lantheus does not currently pay dividends.
What is Lantheus’s EPS estimate?
Lantheus’s EPS estimate is $1.56.
How many shares outstanding does Lantheus have?
Lantheus has 69,430,640 shares outstanding.
What happened to Lantheus’s price movement after its last earnings report?
Lantheus reported an EPS of $1.8 in its last earnings report, missing expectations of $1.83. Following the earnings report the stock price went down -4.5%.
Which hedge fund is a major shareholder of Lantheus?
Among the largest hedge funds holding Lantheus’s share is Farallon Capital Management, L.L.C.. It holds Lantheus’s shares valued at 183M.
---
Lantheus Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$146.25 (35.24% Upside)
$146.25 (35.24% Upside)
Blogger Sentiment
Bullish
LNTH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 5.2%
Last 30 Days ▲ 5.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.84%
12-Months-Change
Fundamentals
Return on Equity
54.26%
Trailing 12-Months
Asset Growth
45.01%
Trailing 12-Months
Company Description
Lantheus
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.
---
LNTH Company Deck
---
LNTH Earnings Call
Q2 2024
0:00 / 0:00
---
LNTH Revenue Breakdown
65.67% PYLARIFY
21.58% DEFINITY
6.74% TechneLite
4.00% Strategic Partnerships and other revenue
2.01% Other
---
LNTH Stock 12 Month Forecast
Average Price Target
$146.25
▲(35.24% Upside)
Technical Analysis
Best Analysts Covering LNTH
1 Year
1 Year Success Rate
11/15 ratings generated profit
1 Year Average Return
+36.74%
reiterated a buy rating 2 months ago
Copying Anthony Petrone's trades and holding each position for 1 Year would result in 73.33% of your transactions generating a profit, with an average return of +36.74% per trade.
---